301 related articles for article (PubMed ID: 29288516)
1. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.
Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L
Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1.
Huang S; Liao Q; Li W; Deng G; Jia M; Fang Q; Ji H; Meng M
Bull Cancer; 2021 Apr; 108(4):359-368. PubMed ID: 33743960
[TBL] [Abstract][Full Text] [Related]
3. [Downregulation of PTTG1 expression inhibits the proliferation and invasiveness and promotes the apoptosis of human prostate cancer LNCaP-AI cells].
Cao XL; Wei YY; Song XM; Lu KQ; Yu WC; Chen YQ; Liu YL; Gao JP
Zhonghua Nan Ke Xue; 2017 Jul; 23(7):589-597. PubMed ID: 29723450
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression.
Duscharla D; Reddy Kami Reddy K; Dasari C; Bhukya S; Ummanni R
J Cell Physiol; 2018 Oct; 233(10):7148-7164. PubMed ID: 29693262
[TBL] [Abstract][Full Text] [Related]
5. [Down-regulated PTTG1 expression promotes the senescence of human prostate cancer LNCaP-AI].
Wei YY; Song XM; Xiong ZH; Lu KQ; Zheng L; Cao XL
Zhonghua Nan Ke Xue; 2019 Mar; 25(3):216-222. PubMed ID: 32216239
[TBL] [Abstract][Full Text] [Related]
6. PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion.
Zhang Z; Jin B; Jin Y; Huang S; Niu X; Mao Z; Xin D
Exp Cell Res; 2017 Jan; 350(1):1-8. PubMed ID: 27756608
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of expression of pituitary tumor transforming gene 1 (PTTG1) by androgen in prostate cancer].
Xin DQ; Zhu XH; Lai YQ; You R; Na YQ; Guo YL; Mao ZB
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):638-40. PubMed ID: 16378119
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
10. Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46.
Liu YN; Niu S; Chen WY; Zhang Q; Tao Y; Chen WH; Jiang KC; Chen X; Shi H; Liu A; Li J; Li Y; Lee YC; Zhang X; Huang J
Clin Cancer Res; 2019 Jul; 25(13):4128-4140. PubMed ID: 30962287
[TBL] [Abstract][Full Text] [Related]
11. [Expression of pituitary tumor-transforming gene 1 during the development of androgen-independent prostate cancer].
Cao XL; Song XM; Yu WC; Chen YQ; Wei YY; Liu YL; Lu KQ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):686-691. PubMed ID: 29019223
[TBL] [Abstract][Full Text] [Related]
12. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
Linder A; Larsson K; Welén K; Damber JE
Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
[TBL] [Abstract][Full Text] [Related]
13. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
14. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
[TBL] [Abstract][Full Text] [Related]
15. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
16. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
Jeong JH; Park SJ; Dickinson SI; Luo JL
Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
[TBL] [Abstract][Full Text] [Related]
17. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.
Begemann D; Wang Y; Yang W; Kyprianou N
Prostate; 2020 Sep; 80(12):926-937. PubMed ID: 32542812
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
19. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.
Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL
Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975
[TBL] [Abstract][Full Text] [Related]
20. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
